yourstate.us
21 CFR 878.4755

§ 878.4755 Absorbable lung biopsy plug.

United States · 21 CFR — Food and Drugs · Status: effective

Get this as JSONEmbed this
Cite this
Citation
21 CFR 878.4755, § 878.4755 Absorbable lung biopsy plug, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/90456
Permanent ID
ys:prov:90456@1
SHA-256
5fc46c4a861b702d3c6dc40dd87df0e47a93939d00d81f06c3f527fc2e1053b1

The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.

Full text

(a) Identification. A preformed (polymerized) absorbable lung biopsy plug is intended to provide accuracy in marking a biopsy location for visualization during surgical resection and closure of pleural punctures associated with percutaneous, transthoracic needle lung biopsies. Upon deployment into the biopsy tract, the plug expands to fill the biopsy void and remains in place until resorbed. (b) Classification. Class II (special controls). The special controls for this device are: (1) The design characteristics of the device must ensure that the geometry and material composition are consistent with the intended use. (2) Performance testing must demonstrate deployment as indicated in the accompanying labeling, including the indicated introducer needles, and demonstrate expansion and resorption characteristics in a clinically relevant environment. (3) In vivo evaluation must demonstrate performance characteristics of the device, including the ability of the plug to not prematurely resorb or migrate and the rate of pneumothorax. (4) Sterility testing must demonstrate the sterility of the device and the effects of the sterilization process on the physical characteristics of the plug. (5) Shelf-life testing must demonstrate the shelf-life of the device including the physical characteristics of the plug. (6) The device must be demonstrated to be biocompatible. (7) Labeling must include a detailed summary of the device-related and procedure-related complications pertinent to the use of the device and appropriate warnings. Labeling must include identification of compatible introducer needles.

Legislative history

This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.